We have confirmed the correlation between IL-33 and markers like SerpinA1, SerpinA3, and EphB2 for SCC and Gli1, Gli2, FOXO3A for BCC as it highlights the complex interplay of cytokines, protease inhibitors, and receptor signaling in cancer. This evidence concerns the gene GLI2 and cancer.